Good Friday morning. For less-distracted reading over the weekend, browse this week’s edition of The Weekly Print, a curated print-friendly PDF featuring a selection of recenteJewishPhilanthropy and Jewish Insider stories, including: At antisemitism-focused Ruderman conference, rabbi whose son was killed on Oct. 7 focuses instead on.
On Nov. 7, 2015, my family received the devastating news that our 9-year-old son Frederico was diagnosed with medulloblastoma, a pediatric brain tumor. At that shattering moment, I made two commitments: one to Frederico, a promise to dedicate my life.
The FDA approved dabrafenib with trametinib for children with previously untreated low-grade glioma who harbor BRAF V600E mutations and require systemic therapy.The approval — which applies to children aged 1 year or older — is the first for a systemic therapy for first-line treatment of this patient population.